- Thirty-two OptumInsight research contributions highlight ongoing commitment to accessibility and affordability for global health care
- OptumInsight Symposium explores the value of innovation in pricing and reimbursement decisions as EU moves to implement “fair price for innovation” in value-based pricing
OptumInsight will join global researchers and thought-leaders at ISPOR Nov. 5-8 in Madrid to examine the latest findings and outcomes in the areas of health care regulatory policy, patient insights, and medical product safety.
On Nov. 5, the OptumInsight life sciences team is sponsoring a timely symposium delving into “Valuing Innovation: Should innovation be considered in pricing and reimbursement of health care technologies?” The symposium features experts from across Europe who will discuss ways of defining and measuring innovation and how this may impact reimbursement decisions and market access.
The symposium presents a case study illustration of the life-cycle value of an innovative technology, and an estimation of how this value is distributed between the innovator or manufacturer and society as a whole. The implications of the results on reimbursement policy will be addressed.
In addition to the educational symposium, OptumInsight life sciences researchers from around the globe contributed thirty-two research studies that include poster sessions, four issue panels, three workshops, a podium presentation and a short course. Topics include: market access, strategic regulatory issues, risk management, comparative drug effectiveness research, impact analysis, health outcomes assessment.
For the full schedule of OptumInsight Life Sciences’ contributions go to: www.optuminsight.com/ISPOReu2011.
Abstracts: November 2011 issue of Value in Health, the official journal of ISPOR, link: http://www.ispor.org/publications/value/JVAL_147_FINAL.pdf. Value in Health is also indexed in Index Medicus/MEDLINE. For Author Inquiries, visit: http:/www.elsevier.com/authors.
About OptumInsight’s Life Sciences Work
OptumInsight’s vision is to be the premier global Life Sciences consultancy through proprietary data, state-of-the-art research and analytics, and health ecosystem knowledge and insight, enabling our clients to:
- Optimize the financial and clinical effectiveness of their marketed ethical pharmaceuticals and medical devices
- Leverage real-world evidence to improve health outcomes and safety
- Achieve rapid and effective market access and product differentiation
- Enhance the value of their R&D pipeline
OptumInsight currently provides service to over 400 leading life science companies worldwide.
Visit www.optum.com or www.optuminsight.com for more information.
